Every cancer is unique and responds differently to a given therapy.
FidoCure Approach
Genetic testing reveals which targeted therapies might work
A dog that is diagnosed with cancer needs love... and science. At FidoCure® we are dog lovers and scientists here to facilitate access to precision medicine as prescribed by your veterinarian.
FidoCure® uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells.
Forrest was diagnosed with splenic cancer and given one month to live. 14 months later, he's happy at home.
Forrest
10 year old golden retriever
Hemophagocytic Histiocytic Sarcoma
“ FidoCure gave us an option when we thought we had none. Forrest has done so well. ”
— Grace , CT
Trusted by the Leading Veterinary Oncologists
“ We believe that targeted therapy will be the standard of care for veterinary oncology in the near future.”
— Dr. Gerald Post · DVM MEM DACVIM
Chief Veterinary Officer, One Health Company
Thousands of dogs have benefitted from FidoCure® options, many of which had limited other options.
Toulouse
“Since starting treatment, Toulouse’s tumors have regressed. FidoCure® brought us hope for Toulouse when we thought we didn’t have any options left.”
— Daniel, FL
Lizzie
“Thanks to FidoCure®, Lizzie is 100% active again, eating well, and in remission for 5 months”
— Kimberley and Francois, CT
Gracie
“[Our vet] told us about the One Health Company’s precision medicine solution, FidoCure®… Now, exactly two months later, Gracie’s cancer is in remission.”
— The Gonzalez Family, FL
As seen on
